- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips captures volumes with new iU22 technology
Philips’ new xMatrix brings real-time volumetric scanning to radiology as part of the company’s latest version of the iU22 ultrasound scanner. First built into Philips’ echocardiography systems five years ago, a souped-up version built into the company’s flagship iU22 on the RSNA exhibit floor quickly captures volumes in the abdomen that can be interrogated in 2D planes any time after the patient has left the exam room. Two planes can be viewed simultaneously using Live xPlane. Images drawn from the volume can then be sent to any PACS.
Philips’ new xMatrix brings real-time volumetric scanning to radiology as part of the company’s latest version of the iU22 ultrasound scanner. First built into Philips’ echocardiography systems five years ago, a souped-up version built into the company’s flagship iU22 on the RSNA exhibit floor quickly captures volumes in the abdomen that can be interrogated in 2D planes any time after the patient has left the exam room. Two planes can be viewed simultaneously using Live xPlane. Images drawn from the volume can then be sent to any PACS.
Integrated with PureWave technology, xMatrix works with the new X6-1 transducer. The combination allows operators of different skill levels to achieve the same quality imaging, according to Philips. The key is the xMatrix transducer with elements arranged along the X and Y planes. The 9000 electronically controlled elements replace the mechanical 3D arrays of the past, capturing volumes of data that can be easily interrogated.
Today this volumetric technology is available only in an abdominal probe, but in time it will become available on Philips’ solid-state transducers for endocavitary, vascular, and small parts applications. While there is no specific timeline for the migration of this technology, Philips executives say the company is definitely headed in this direction.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
